The comparison of creatinine and cystatin C value in preeclampsia severity and neonatal outcome
Downloads
Objectives: to compare the levels of creatinine and cystatin C with the severity of preeclampsia, and assess neonatal outcomes.
Materials and Methods: Creatinine, cystatin C, and neonatal outcomes were assesed in 17 normotensive samples, 17 samples of mild preeclampsia and 17 samples of severe preeclampsia. Analysis of data with statistical tests of ANOVA and t test differences between 2 proportions.
Results: The mean levels of creatinine in the normotensive group, mild preeclampsia, severe preeclampsia are 0.56 mg/dL, 0.67 mg/ dL, and 0.75 mg/dL, p=0.138; While on cystatin C are 0.82 mg/L, 1.03 mg/L and 1.32 mg/L, p=0.000. The adverse neonatal out-come wasn't found in the normotensive group. In mild pre-eclampsia obtained 1 preterm birth and 1 intrauterine fetal death (IUFD), whereas in severe preeclampsia obtained 3 babies born preterm, 1 IUFD, and 1 intrauterine growth restriction (IUGR).
Conclusion: levels of cystatin C was increased significantly in line with increased severity of preeclampsia, whereas creatinine was not increased significantly. Cystatin C is better than crea-tinine as a marker of renal dysfunction in preeclampsia patients. There was an increase in adverse neonatal outcomes in the group of preeclampsia.
Chappell S, Morgan L. Searching for genetic clues to the causes of pre-eclampsia. Clin Sci (Lond). 2006;110(4):443–58.
Kementrian Kesehatan. Profil Kesehatan Indonesia Tahun 2013. Jakarta: Kementerian Kesehatan RI; 2014. hal. 507.
Takahashi WH, Silvio M, Khoury MY, Lopes RGC, Garcia SAL, Lippi UG. Assessment of serum lipids in pregnant women aged over 35 years and their relation with pre-eclampsia. 2008.
Sumithra K, Vibha C, Vishwanath HL. Studyof Serum Cystatin C in Pre-Eclampsia.
Kristensen K, Wide-Swensson D, Schmidt C, Blirup-Jensen S, Lindström V, Strevens H, et al. Cystatin C, beta-2-microglobulin and beta-trace protein in pre-eclampsia. Acta Obstet Gynecol Scand. 2007;86(8):921-6.
Mares J, Stejskal D, Vavrousková J, Urbánek K, Herzig R, Hlustík P. Use of cystatin C determination in clinical diagnostics. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2003;147(2):177-80.
Padma Y, Aparna VB, Kalpana B, Ritika V, Sudhakar PR. Renal markers in normal and hypertensive disorders of pregnancy in Indian women: a pilot study. Int J Reprod Contraception. Obstet Gynecol. 2013;2(4):514-20.
Filler G, Bökenkamp A, Hofmann W, Le Bricon T, Martínez-Brú C, Grubb A. Cystatin C as a marker of GFR”history, indications, and future research. Clin Biochem. 2005;38(1):1-8.
Garovic VD, Wagner SJ, Turner ST, Rosenthal DW, Watson WJ, Brost BC, et al. Urinary podocyte excretion as a marker for preeclampsia. Am J Obstet Gynecol. 2007;196(4):1-7.
Strevens H, Wide-Swensson D, Grubb A, Hansen A, Horn T, Ingemarsson I, et al. Serum cystatin C reflects glomerular endotheliosis in normal, hypertensive and pre-eclamptic pregnancies. BJOG An Int J Obstet Gynaecol. Blackwell Science Ltd. 2003;110(9):825-30.
Farag MK, Maksoud NA El, Ragab HM, Gaber KR. Predictive value of cystatin C and beta-2 microglobulin in preeclampsia. J Genet Eng Biotechnol. 2011;9(2):133-6.
Strevens H, Justnu. Blood pressure, renal functional and structural changes, in normal and preeclamptic pregnancy. Helena Strevens, Department of Obstetrics and Gynecology, University Hospital Sweden. 2002;221(85).
Franceschini N, Qiu C, Barrow DA, Williams MA. Cystatin C and preeclampsia: a case control study. Ren Fail. 2008;30(1):89-95.
Backes CH, Markham K, Moorehead P, Cordero L, Nankervis CA, Giannone PJ, et al. Maternal Preeclampsia and Neonatal Outcomes. J Pregnancy. Hindawi Publishing Corporation. 2011:1-7.
Aabidha PM, Cherian AG, Paul E, Helan J. Maternal and fetal outcome in pre-eclampsia in a secondary care hospital in South India. J Fam Med Prim care. 2015;4(2):257-60.
Roberts JM, Gammill HS. Preeclampsia: recent insights. Hypertension. 2005;46(6):1243-9.
Sharma S, Ranjan RK, Gupta M, Singh A, Gupta R, Pant L. Original Article Serum Cystatin C compared with conventional renal function tests : A study in patients with pre-eclampsia. 2014;1(2):6-9.
Isasari, et al. Maternal Cystatin C Serum is Higher in Women with Severe Preeclampsia. Indones J Obs Gynecol. 2014;2(1):22-7.
Costa RA, Peracoli MT, Romí£o M, Weel IC, Abbade JF, Peracoli JC. Pregnancy Hypertens An Int J Women's Cardiovasc Heal. Elsevier; 2015;5(1):64.
Young PC, Glasgow TS, Li X, Guest-Warnick G, Stoddard G. Mortality of late-preterm (near-term) newborns in Utah. Pediatrics. 2007;119(3):659-65.
1. Copyright of the article is transferred to the journal, by the knowledge of the author, whilst the moral right of the publication belongs to the author.
2. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution-Non Commercial-Share alike (CC BY-NC-SA), (https://creativecommons.org/licenses/by-nc-sa/4.0/)
3. The articles published in the journal are open access and can be used for non-commercial purposes. Other than the aims mentioned above, the editorial board is not responsible for copyright violation
The manuscript authentic and copyright statement submission can be downloaded ON THIS FORM.
